Published in Diabetes Care on February 01, 2005
Effects of self-management support on structure, process, and outcomes among vulnerable patients with diabetes: a three-arm practical clinical trial. Diabetes Care (2009) 2.02
Oral bisphosphonate compliance and persistence: a matter of choice? Osteoporos Int (2010) 1.07
Impact of phone call intervention on glycemic control in diabetes patients: a systematic review and meta-analysis of randomized, controlled trials. PLoS One (2014) 0.99
A qualitative synthesis of diabetes self-management strategies for long term medical outcomes and quality of life in the UK. BMC Health Serv Res (2014) 0.94
Telemedicine-based KADIS combined with CGMS has high potential for improving outpatient diabetes care. J Diabetes Sci Technol (2007) 0.91
Enhancing health literacy and behavioural change within a tele-care education and support intervention for people with type 2 diabetes. Health Expect (2011) 0.90
An evaluation of Birmingham Own Health telephone care management service among patients with poorly controlled diabetes. A retrospective comparison with the General Practice Research Database. BMC Public Health (2011) 0.89
Managing the space between visits: a randomized trial of disease management for diabetes in a community health center. J Gen Intern Med (2010) 0.86
Cost-effectiveness of health-related lifestyle advice delivered by peer or lay advisors: synthesis of evidence from a systematic review. Cost Eff Resour Alloc (2013) 0.81
Telephone based self-management support by 'lay health workers' and 'peer support workers' to prevent and manage vascular diseases: a systematic review and meta-analysis. BMC Health Serv Res (2013) 0.80
The Inclusion of Ethnic Minority Patients and the Role of Language in Telehealth Trials for Type 2 Diabetes: A Systematic Review. J Med Internet Res (2016) 0.79
Effect of telemedicine on glycated hemoglobin in diabetes: a systematic review and meta-analysis of randomized trials. CMAJ (2016) 0.78
Using the health action process approach to predict and improve health outcomes in individuals with type 2 diabetes mellitus. Diabetes Metab Syndr Obes (2014) 0.75
Technology-Intensified Diabetes Education Study (TIDES) in African Americans with type 2 diabetes: study protocol for a randomized controlled trial. Trials (2014) 0.75
The cost-effectiveness of hospital-based telephone coaching for people with type 2 diabetes: a 10 year modelling analysis. BMC Health Serv Res (2016) 0.75
Penicillin to prevent recurrent leg cellulitis. N Engl J Med (2013) 4.84
Antioxidant therapy does not reduce pain in patients with chronic pancreatitis: the ANTICIPATE study. Gastroenterology (2012) 4.74
Effectiveness of enhanced communication therapy in the first four months after stroke for aphasia and dysarthria: a randomised controlled trial. BMJ (2012) 4.01
The serine protease TMPRSS6 is required to sense iron deficiency. Science (2008) 3.70
Type 2 diabetes whole-genome association study in four populations: the DiaGen consortium. Am J Hum Genet (2007) 3.31
Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials. J Hypertens (2006) 3.29
Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1 expression independently of Hfe, transferrin receptor 2 (Tfr2), and IL-6. Proc Natl Acad Sci U S A (2006) 3.13
High prevalence of undetected heart failure in long-term care residents: findings from the Heart Failure in Care Homes (HFinCH) study. Eur J Heart Fail (2012) 2.43
Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy. Kidney Int (2011) 2.34
Automated electronic reminders to facilitate primary cardiovascular disease prevention: randomised controlled trial. Br J Gen Pract (2010) 2.32
The unrecognized prevalence of chronic kidney disease in diabetes. Nephrol Dial Transplant (2005) 2.24
EPO-mediated reduction in Hamp expression in vivo corrects iron deficiency anaemia in TMPRSS6 deficiency. Br J Haematol (2010) 2.20
Specialist nurse-led intervention to treat and control hypertension and hyperlipidemia in diabetes (SPLINT): a randomized controlled trial. Diabetes Care (2003) 2.19
Recombinant HMGB1 with cytokine-stimulating activity. J Immunol Methods (2004) 2.14
Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study. Lancet (2002) 2.12
The use of patient reported outcome measures in routine clinical practice: lack of impact or lack of theory? Soc Sci Med (2005) 2.05
Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis. Neurology (2005) 2.00
Square pegs and round holes? A review of economic evaluation in complementary and alternative medicine. J Altern Complement Med (2005) 1.76
Haptoglobin polymorphism and iron homeostasis. Clin Chem (2002) 1.63
Systematic review of rosacea treatments. J Am Acad Dermatol (2006) 1.62
Evaluating complementary medicine: methodological challenges of randomised controlled trials. BMJ (2002) 1.61
Surgical excision margins for primary cutaneous melanoma. Cochrane Database Syst Rev (2009) 1.60
Planning and analysis of three-arm non-inferiority trials with binary endpoints. Stat Med (2007) 1.54
The liver-first approach to the management of colorectal cancer with synchronous hepatic metastases: a systematic review. JAMA Surg (2013) 1.52
Telomere elongation (Tel), a new mutation in Drosophila melanogaster that produces long telomeres. Genetics (2002) 1.48
Warwick-Edinburgh Mental Well-being Scale (WEMWBS): validated for teenage school students in England and Scotland. A mixed methods assessment. BMC Public Health (2011) 1.45
Tacit and encoded knowledge in the use of standardised outcome measures in multidisciplinary team decision making: a case study of in-patient neurorehabilitation. Soc Sci Med (2008) 1.41
Robustness of methods for blinded sample size re-estimation with overdispersed count data. Stat Med (2013) 1.39
Lifestyle interventions or drugs for patients with essential hypertension: a systematic review. J Hypertens (2004) 1.38
Suppression of the hepcidin-encoding gene Hamp permits iron overload in mice lacking both hemojuvelin and matriptase-2/TMPRSS6. Br J Haematol (2009) 1.36
Barriers to accurate diagnosis and effective management of heart failure have not changed in the past 10 years: a qualitative study and national survey. BMJ Open (2014) 1.36
Buyer beware? Does the information provided with herbal products available over the counter enable safe use? BMC Med (2011) 1.34
Different regulatory elements are required for response of hepcidin to interleukin-6 and bone morphogenetic proteins 4 and 9. Br J Haematol (2007) 1.33
Telephone peer-delivered intervention for diabetes motivation and support: the telecare exploratory RCT. Patient Educ Couns (2008) 1.32
A new approach to outcome prediction in trauma: A comparison with the TRISS model. J Trauma (2006) 1.31
Autosomal dominant hereditary hemochromatosis associated with a novel ferroportin mutation and unique clinical features. Blood Cells Mol Dis (2005) 1.30
Abnormalities on magnetic resonance imaging seen acutely following mild traumatic brain injury: correlation with neuropsychological tests and delayed recovery. Neuroradiology (2004) 1.28
Nonmotor and diagnostic findings in subjects with de novo Parkinson disease of the DeNoPa cohort. Neurology (2013) 1.26
A group-sequential design for clinical trials with treatment selection. Stat Med (2008) 1.20
Clinical evaluation of the efficacy of the P2X7 purinergic receptor antagonist AZD9056 on the signs and symptoms of rheumatoid arthritis in patients with active disease despite treatment with methotrexate or sulphasalazine. Ann Rheum Dis (2012) 1.19
Factors associated with kidney disease progression and mortality in a referred CKD population. Am J Kidney Dis (2010) 1.18
Two distinct domains in Drosophila melanogaster telomeres. Genetics (2005) 1.15
Euglycemic hyperinsulinemia augments the cytokine and endocrine responses to endotoxin in humans. Am J Physiol Endocrinol Metab (2002) 1.14
Deep vein thromboses in users of opioid drugs: incidence, prevalence, and risk factors. Br J Gen Pract (2011) 1.13
Simple procedures for blinded sample size adjustment that do not affect the type I error rate. Stat Med (2003) 1.13
Effects of fostamatinib, an oral spleen tyrosine kinase inhibitor, in rheumatoid arthritis patients with an inadequate response to methotrexate: results from a phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. Arthritis Rheumatol (2014) 1.09
Two BMP responsive elements, STAT, and bZIP/HNF4/COUP motifs of the hepcidin promoter are critical for BMP, SMAD1, and HJV responsiveness. Blood (2008) 1.09
Uncertainty method improved on best-worst case analysis in a binary meta-analysis. J Clin Epidemiol (2005) 1.08
Retrotransposition-Competent Human LINE-1 Induces Apoptosis in Cancer Cells With Intact p53. J Biomed Biotechnol (2004) 1.08
In vivo imaging of hepcidin promoter stimulation by iron and inflammation. Blood Cells Mol Dis (2007) 1.07
Derivation and validation of a prediction score for major coronary heart disease events in a U.K. type 2 diabetic population. Diabetes Care (2006) 1.07
Association between insulin-like growth factor-I: insulin-like growth factor-binding protein-1 ratio and metabolic and anthropometric factors in men and women. Cancer Epidemiol Biomarkers Prev (2004) 1.04
The use of eGFR and ACR to predict decline in renal function in people with diabetes. Nephrol Dial Transplant (2010) 1.04
Specialist nurse-led clinics to improve control of hypertension and hyperlipidemia in diabetes: economic analysis of the SPLINT trial. Diabetes Care (2005) 1.03
Complementary therapy use by persons with multiple sclerosis: benefits and research priorities. Complement Ther Clin Pract (2008) 1.03
Abrogation of insulin-like growth factor-I (IGF-I) and insulin action by mevalonic acid depletion: synergy between protein prenylation and receptor glycosylation pathways. J Biol Chem (2004) 1.03
A comparison of peritonitis in polycystic and non-polycystic patients on peritoneal dialysis. Perit Dial Int (2004) 1.03
Identification of a novel mutation in the CDHR1 gene in a family with recessive retinal degeneration. Arch Ophthalmol (2012) 1.02
The distal location of the iron responsive region of the hepcidin promoter. Blood (2007) 1.02
Methods underpinning national clinical guidelines for hypertension: describing the evidence shortfall. BMC Health Serv Res (2006) 1.01
HP1 is distributed within distinct chromatin domains at Drosophila telomeres. Genetics (2008) 0.99
The realisation of patient-centred care during a 3-year proactive telephone counselling self-care intervention for diabetes. Patient Educ Couns (2009) 0.98
Brain iron metabolism and neurodegenerative disorders. Dev Neurosci (2002) 0.98
Radiation resistance in glioma cells determined by DNA damage repair activity of Ape1/Ref-1. J Radiat Res (2010) 0.98
Impaired glucose tolerance and insulin resistance in heart failure: underrecognized and undertreated? J Card Fail (2010) 0.98
C-reactive protein and the insulin-like growth factor (IGF)-system in relation to risk of cardiovascular disease in different ethnic groups. Atherosclerosis (2003) 0.98
Cross cultural evaluation of the Warwick-Edinburgh Mental Well-being Scale (WEMWBS) --a mixed methods study. Health Qual Life Outcomes (2013) 0.98
Pain assessment for people with dementia: a systematic review of systematic reviews of pain assessment tools. BMC Geriatr (2014) 0.97
Sources of information and behavioral patterns in online health forums: observational study. J Med Internet Res (2014) 0.97
Anticholinergics for urinary symptoms in multiple sclerosis. Cochrane Database Syst Rev (2009) 0.96
Safety and Efficacy of the ACE-Inhibitor Ramipril in Alport Syndrome: The Double-Blind, Randomized, Placebo-Controlled, Multicenter Phase III EARLY PRO-TECT Alport Trial in Pediatric Patients. ISRN Pediatr (2012) 0.96
Outcome prediction in trauma. Injury (2006) 0.96
Erythropoietin, GDF15, IL6, hepcidin and testosterone levels in a large cohort of elderly individuals with anaemia of known and unknown cause. Eur J Haematol (2011) 0.95
Significance of microalbuminuria in long-duration type 1 diabetes. Diabetes Care (2003) 0.95
Protein landscape at Drosophila melanogaster telomere-associated sequence repeats. Mol Cell Biol (2012) 0.94
The role of STAT, AP-1, E-box and TIEG motifs in the regulation of hepcidin by IL-6 and BMP-9: lessons from human HAMP and murine Hamp1 and Hamp2 gene promoters. Blood Cells Mol Dis (2007) 0.93
Exome analysis identified a novel mutation in the RBP4 gene in a consanguineous pedigree with retinal dystrophy and developmental abnormalities. PLoS One (2012) 0.93
Relaxation therapies for the management of primary hypertension in adults. Cochrane Database Syst Rev (2008) 0.93
Recognition of double strand breaks by a mutator protein (MU2) in Drosophila melanogaster. PLoS Genet (2009) 0.93
Significant ethnic variation in total and free testosterone concentration. Clin Endocrinol (Oxf) (2003) 0.92
Adaptive designs for confirmatory clinical trials with subgroup selection. J Biopharm Stat (2014) 0.91
The problem with measuring patient perceptions of outcome with existing outcome measures in foot and ankle surgery. Foot Ankle Int (2003) 0.91
Bladder symptoms in multiple sclerosis: a review of pathophysiology and management. Expert Opin Drug Saf (2010) 0.91
Low circulating IGF-II concentrations predict weight gain and obesity in humans. Diabetes (2003) 0.91
Apposite insulin-like growth factor (IGF) receptor glycosylation is critical to the maintenance of vascular smooth muscle phenotype in the presence of factors promoting osteogenic differentiation and mineralization. J Biol Chem (2011) 0.90
A retrospective survey of patients at the University of Salford Acupuncture Clinic. Complement Ther Clin Pract (2006) 0.90
A novel adaptive design strategy increases the efficiency of clinical trials in secondary progressive multiple sclerosis. Mult Scler (2010) 0.90
Enhancing health literacy and behavioural change within a tele-care education and support intervention for people with type 2 diabetes. Health Expect (2011) 0.90
Diagnostic and prognostic value of plasma tumor M2 pyruvate kinase in periampullary cancer: evidence for a novel biological marker of adverse prognosis. Pancreas (2007) 0.89
Acceptability and satisfaction with a telecarer approach to the management of type 2 diabetes. Diabetes Care (2005) 0.89
Qualitative data analysis using data displays. Nurse Res (2005) 0.89